Skip to main content

Table 1 Pre-treatment characteristics for the study population

From: Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study

Pre-treatment characteristics

All (n = 207)a

Venlafaxine (n = 98)a

Sertraline (n = 109)a

N(%)

Demographic information

Male gender

124 (60.2)

61 (62.2)

63 (58.3)

Country of origin

 Ex-Yugoslavia

20 (9.7)

11 (11.2)

9 (8.3)

 Iran

28 (13.6)

13 (13.3)

15 (13.9)

 Iraq

71 (34.5)

34 (34.7)

37 (34.3)

 Afghanistan

28 (13.6)

10 (10.2)

18 (16.7)

 Lebanon

26 (12.6)

12 (12.2)

14 (13.0)

 Other

33 (16.2)

18 (18.4)

15 (13.9)

Diagnosis (ICD-10) in addition to PTSD

 Depression

204 (98.6)

96 (97.96)

108 (99.08)

 Enduring personality change after catastrophic experience (F.62.0)

80 (40.8)

38 (41.30)

42 (40.38)

 Other psychiatric disorder

24 (11.7)

12 (12.24)

12 (11.11)

Trauma history

 Imprisonment

110 (53.4)

57 (58.8)

53 (48.6)

 Torture**

99 (48.1)

54 (55.1)

45 (41.7)

 Refugee camp

52 (25.7)

22 (22.9)

30 (27.5)

Psychosocial status

 Education >10 years from home country

98 (50.8)

50 (53.2)

48 (48.5)

 Presently employed/studying

14 (7.0)

7 (7.3)

7 (6.8)

 Living alone all the time

51 (25.8)

21 (21.9)

30 (29.4)

 Have got children less than 18 years old

137 (68.8)

68 (70.8)

69 (67.0)

Mean(SD)

 Age

43.7 (9.7)

43.2 (9.6)

44.0 (9.7)

 Years since arrival in Denmark

14.6 (7.3)

14.1 (7.1)

15.1 (7.4)

  1. Pre-treatment characteristics for the venlafaxine and sertraline groups
  2. N Number of study participants, SD Standard deviation
  3. ** Group difference borderline significant, p = 0.054
  4. aNot all variables available for the entire patient group